🔎 Trials Near Me

Home › Urothelial (Transitional Cell) Carcinoma › Ohio › Cleveland

Urothelial (Transitional Cell) Carcinoma clinical trials in Cleveland, OH

8 studies for Urothelial (Transitional Cell) Carcinoma are looking for participants at sites in and around Cleveland (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

RecruitingPhase 1
  • Exelixis Clinical Site #10, Cleveland
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT05176483

Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma

Recruiting
  • University Hospitals Cleveland Medical Center, Urology Institute, Case Comprehensive Cancer Center, Cleveland
  • Cleveland Clinic Glickman Urological and Kidney Institute, Cleveland
Ages 19 and older · All sexes · Updated Oct 1, 2026 · NCT06262516

A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)

RecruitingPhase 1/2
  • Cleveland Clinic-Taussig Cancer Center ( Site 1036), Cleveland
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05562830

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

RecruitingPhase 1/2
  • University Hospitals Cleveland Medical Center, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • Cleveland Clinic Taussig Cancer Center Investigational Pharmacy, Cleveland
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07421700

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

RecruitingPhase 1
  • Cleveland Clinic, Cleveland
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06966024

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

RecruitingPhase 3
  • Research Site, Cleveland
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT07720284

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

RecruitingPhase 2
  • University Hospitals Cleveland Medical Center, Cleveland
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT04879329

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi away
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Urothelial (Transitional Cell) Carcinoma trials in other cities

Other studies in Cleveland

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.